Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

These drugs are currently prescribed for the treatment of many neuropathic pain conditions. Impart a hyperexcitable state to neurons, thereby producing intense neuronal activity that contributes ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Certain conditions, such as diabetes, may increase your risk of neuropathy, which could lead to neuropathic pain. CBD lotions, creams, and salves may help reduce aches and pains. It’s unclear ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...